No significant correlation was found with CD8+/CD4+ T cells or tumor purity (Figure 7), implying that antigen-presenting cells (APCs) in KIRC with low PAQR5 expression may be less expressed and unable to respond to the antitumor immune response, resulting in immune dysfunction. The gene discussed is CD8A; the disease is neoplasm.